Emergent Health Corp (EMGE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2013 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.21 Million | -1.89 Million | -161.62 Thousand | -57.25 Thousand | -54.23 Thousand | 76.97 Thousand |
| Net Income | -1.62 Million | -2.1 Million | -288.76 Thousand | -79.12 Thousand | -67.49 Thousand | 121.02 Thousand |
| Depreciation & Amortization | 20 Thousand | 20 Thousand | 20 Thousand | 20 Thousand | 10 Thousand | 352.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 68.03 Thousand | 191.37 Thousand | 20.54 Thousand | 5215.00 | 4330.00 | -44.4 Thousand |
| Other non-cash items | 292.21 Thousand | -208.26 Thousand | 106.04 Thousand | -3341.00 | 15.5 Thousand | 24.15 Thousand |
| Investing Cash Flow | 160 Thousand | -634.39 Thousand | - | - | - | - |
| Investments in PPE | 2.00 | -50 Thousand | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 160 Thousand | -584.39 Thousand | - | - | - | - |
| Financing Cash Flow | 1.07 Million | 2.3 Million | 250 Thousand | - | 90 Thousand | - |
| Debt repayment | -820.91 Thousand | -1.29 Million | -250 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 250.5 Thousand | 1 Million | - | - | 90 Thousand | - |
| Other Financing Activities | - | - | 250.00 | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 68.03 Thousand | 178.65 Thousand | 9580.00 | - | - | 26.75 Thousand |
| Inventory | - | 69.61 Thousand | 10.96 Thousand | 5215.00 | 3422.00 | -50.21 Thousand |
| Other working capital | - | -56.89 Thousand | - | - | 908.00 | -20.95 Thousand |
| Cash at beginning of period | 13.25 Thousand | 257.76 Thousand | 226.64 Thousand | 226.64 | 814.26 Thousand | 737.30 |
| Cash at end of period | 24.86 Thousand | 13.25 Thousand | 257.76 Thousand | 169.39 Thousand | 226.64 Thousand | 814.26 Thousand |
| Capital Expenditure | 2.00 | -50 Thousand | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 11.6 Thousand | -244.5 Thousand | 31.12 Thousand | 169.16 Thousand | -587.62 Thousand | 813.53 Thousand |
| Free Cash Flow | -1.21 Million | -1.94 Million | -161.62 Thousand | -57.25 Thousand | -54.23 Thousand | 76.97 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 90.66 Thousand | -413.78 Thousand | -1.62 Million | -256.75 Thousand | -726.04 Thousand | -255.86 Thousand |
| Depreciation & Amortization | 5000.00 | 5000.00 | 20 Thousand | 5000.00 | 5000.00 | 5000.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 112.94 Thousand | -65.91 Thousand | 68.03 Thousand | -413.41 Thousand | 582.71 Thousand | -101.55 Thousand |
| Other non-cash items | -41.34 Thousand | 138.21 Thousand | 292.21 Thousand | -3897.00 | -307.61 Thousand | 110.3 Thousand |
| Investing Cash Flow | - | - | 160 Thousand | 160 Thousand | -33.71 Thousand | 50.75 Thousand |
| Investments in PPE | 3.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | -33.71 Thousand | 33.71 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 160 Thousand | 160 Thousand | - | 17.03 Thousand |
| Financing Cash Flow | -317.26 Thousand | 434.72 Thousand | 1.07 Million | 380.51 Thousand | 39.31 Thousand | 274 Thousand |
| Debt repayment | -317.26 Thousand | -434.72 Thousand | -820.91 Thousand | -380.51 Thousand | -48 Thousand | -214 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 250.5 Thousand | - | -8685.00 | 60 Thousand |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | -4033.00 | -73.25 Thousand | - | - | 160 Thousand | - |
| Accounts payables | 116.97 Thousand | 7340.00 | 68.03 Thousand | 87.84 Thousand | 349.41 Thousand | -100.3 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | 73.29 Thousand | - |
| Cash at beginning of period | 47.19 Thousand | 24.86 Thousand | 13.25 Thousand | 75.58 Thousand | 16.5 Thousand | 44.16 Thousand |
| Cash at end of period | 123.00 | 47.19 Thousand | 24.86 Thousand | 24.86 Thousand | 75.58 Thousand | 16.5 Thousand |
| Capital Expenditure | 3.00 | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -47.07 Thousand | 22.32 Thousand | 11.6 Thousand | -50.71 Thousand | 59.07 Thousand | -27.66 Thousand |
| Free Cash Flow | 270.2 Thousand | -412.39 Thousand | -1.21 Million | -591.22 Thousand | 53.47 Thousand | -352.41 Thousand |
4008
JINDALSAW
5595
PHR
REFR
FJTSY